Biggest News Aggregation in the World
📰 Eppendorf News

Page 17 - Eppendorf News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Eppendorf. Real-time updates on events, politics, business and more.

Despite evidence of durability, belantamab mafodotin misses endpoint for multiple myeloma

CHICAGO — Belantamab mafodotin monotherapy did not significantly extend PFS compared with the combination of pomalidomide and dexamethasone among adults with relapsed or refractory multiple myeloma, phase 3 study results showed. However, data from the randomized trial presented at ASCO Annual Meeting suggest that single-agent treatment with belantamab mafodotin (Blenrep, GSK) may have
Nordrhein Westfalen United States Joshua Richter Mindy Valcarcel Katja Weisel Bydrew Amorosi
Source: healio.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science